Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Assets: 2011-2025

Historic Assets for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $319.0 million.

  • Mimedx Group's Assets rose 30.79% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $319.0 million, marking a year-over-year increase of 30.79%. This contributed to the annual value of $263.9 million for FY2024, which is 10.40% up from last year.
  • As of Q3 2025, Mimedx Group's Assets stood at $319.0 million, which was up 9.58% from $291.1 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Assets peaked at $319.0 million during Q3 2025, and registered a low of $168.2 million during Q1 2023.
  • Its 3-year average for Assets is $237.5 million, with a median of $239.0 million in 2023.
  • Per our database at Business Quant, Mimedx Group's Assets fell by 15.38% in 2021 and then surged by 39.44% in 2023.
  • Quarterly analysis of 5 years shows Mimedx Group's Assets stood at $187.9 million in 2021, then declined by 8.78% to $171.4 million in 2022, then soared by 39.44% to $239.0 million in 2023, then rose by 10.40% to $263.9 million in 2024, then spiked by 30.79% to $319.0 million in 2025.
  • Its last three reported values are $319.0 million in Q3 2025, $291.1 million for Q2 2025, and $270.4 million during Q1 2025.